EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) fair value: what the stock is really worth

As of Sep 25, 2026: fair value of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC $0.00, price $0.00, upside -0.6%, quality 37 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · US

VV Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC logo Thin data Sep 27, 2026

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC

VENCF · US

Low PriorityFair Value upside is limited and quality is weak.

·Fair value $0.0018 · Fairly valued (−0.6%)
!Quality 37/100
!Weak Growth
!Loss-making · -91.1% net margin (TTM)
!negative free cash flow
!Trails peers (3/9)
!Narrow moat 8/100
!Evidence only low, so the estimate is less certain
Watch Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.0018 $0.0009 Fair Value $0.0018 Apr 2026 Sep 2026

White line = price, green steps = our fair value per fiscal year. As of Sep 27, 2026.

How to read this chart

5‑month range $0.0009 – $0.0018 · fair‑value band $0.0018 – $0.0018 · the $0.0018 price screens above the $0.0018 fair value. As of Sep 27, 2026.

Follow Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC in your weekly email

Every Wednesday you see whether Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is a venture capital firm specializing in seed/startups and early venture. It prefers to invest in cannabis sectors. The firm prefers to invest in companies based in United States, North America and beyond. Vencanna Ventures Inc. is based in Calgary, Canada.

Stock analysis

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) currently trades at $0.0018, while our model-based Fair Value estimate is $0.0018, so the stock looks roughly fairly valued today (gap 0.6%).

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 76/100, which puts the evidence level at low.

Scenario range: $0.0018 (bear) to $0.0018 (bull), the price of $0.0018 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC reported revenue of $4.0M in FY2025 versus $0 in FY2022. Reported net income was −$3.9M in FY2025.

Key figures

Market cap $401K · P/S ratio 0.11 · EPS (TTM) $−0.0100 · Net margin −96.2% · Return on equity −155% · Return on assets (EBIT) −18.2% · Operating margin −61.1% · Revenue (TTM) $2.0M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (medium confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at −1%, VENCF screens cheaper than that median.

Fair Value models

Bear $0.0018 Fair Value $0.0018 Bull $0.0018
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $0.0100 $0.0100 $0.0200 50
All 1 models by family
Asset-Based
NCAV (Graham) $0.0100 $0.0100 $0.0200 50

Open the full fair value analysis →

Notify me when VENCF reaches fair value

Put VENCF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 37/100

Of which business quality 37 · Market factors (momentum, volatility) 79

Profitability 12
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 59
Balance sheet, leverage, solvency risk
Investment 85
Disciplined investing over empire-building
Low Volatility 30
Calm price path (market factor)
Momentum 100
Price trend over the last 3–12 months (market factor)
52W Momentum 100
Distance to the 52-week high (market factor)
Net Issuance 44
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch VENCF, get fair value alerts →

Compare Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 585 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 37 · Bottom 25%
Fair Value upside −0.6% · Above median
Profitability
Return on assets −24.8% · Bottom 25%
Net margin (TTM) −91.1% · Bottom 25%
Operating margin (TTM) −61.1% · Bottom 25%
Growth and dividend
Revenue growth −56.7% · Bottom 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B 0.11× · Cheapest 25%
P/S (TTM) 0.20× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)33 · sector 14
FUTURE (revenue growth)0 · sector 24
PAST (return on equity)0 · sector 28
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €134.45 €108.94 −19%
Takeda Pharmaceutical Company TAK $18.90 $11.45 −39%
Teva Pharmaceutical Industries Limited TEVA $39.19 $20.88 −47%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,852 ₹1,979 +7%
Galderma Group GALD CHF 163.00 CHF 110.32 −32%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥44.86 ¥49.35 +10%
Haleon plc HLN $9.26 $8.49 −8%
Sandoz Group SDZ CHF 71.16 CHF 40.32 −43%
Zoetis Inc ZTS $70.30 $110.50 +57%
Divi's Laboratories Limited DIVISLAB ₹9,620 ₹1,871 −81%

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC Fair Value". https://www.fairvalue-calculator.com/stock/VENCF

Frequently asked questions

Is Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0018 versus the last price from Sep 25, 2026 of $0.0018, about −1% upside (fairly valued).
What is the fair value of VENCF?
Our model-based fair value for Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is $0.0018 (as of Sep 27, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $0.0018.
What is the quality score of VENCF?
Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
Our model-based price target is the fair value of $0.0018 (as of Sep 27, 2026) from 1 valuation models. Cautious scenario $0.0018, optimistic scenario $0.0018. It is a calculation from audited fundamentals, not an analyst target.
What is the Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC stock forecast for 2026?
Our models put fair value at $0.0018, about −1% upside versus the last price from Sep 25, 2026 of $0.0018 (fairly valued). Cautious scenario $0.0018, optimistic scenario $0.0018. The calculation is refreshed regularly with new filings.
What is the revenue of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC reported trailing-twelve-month revenue of about $2.0M (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC it is $0.0018 per share (as of Sep 27, 2026), against a price of $0.0018. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC stock overvalued or undervalued in 2026?
As of Sep 27, 2026, VENCF trades above its calculated fair value: price $0.0018, fair value $0.0018, a gap of about −1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VENCF?
No. The price is what the market pays today ($0.0018); the fair value is what the company's own numbers justify ($0.0018). For Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC worth?
The market values Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC at about $401K (market capitalisation, as of Sep 27, 2026). Per share that is $0.0018; our models calculate a fair value of $0.0018 per share.
What do the bullish and bearish scenarios say about VENCF?
Our models span a range for Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC: cautious scenario $0.0018, base $0.0018, optimistic $0.0018 per share (as of Sep 27, 2026, price $0.0018). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
Balance-sheet figures for Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (as of Sep 27, 2026): return on equity −155.3%. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
Which stocks are comparable to Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0018, calculated fair value $0.0018 (−1%), Quality Score 37/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VENCF calculated?
We run Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0018, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
The latest price we hold is from Sep 25, 2026 and stands at $0.0018. Our model-based fair value is $0.0018, about −1% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0018 to $0.0018), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC

How large is the market capitalisation of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
The market capitalisation of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is $401K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
The price-to-sales ratio of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is 0.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
Earnings per share at Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
The net margin of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is −96.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
The return on equity (ROE) of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is −155% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
On an EBIT basis the return on assets of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is −18.2% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
The operating margin of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is −61.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
Revenue at Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is growing −56.7% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) generate?
The free cash flow of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is −$1.3M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC in the live analysis

One click puts Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.